Cognitive Rehabilitation for People With Mild-to-moderate Dementia

Launched by NHS GREATER GLASGOW AND CLYDE · Sep 29, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring a program called Cognitive Rehabilitation (CR) designed to help people with mild-to-moderate dementia manage everyday tasks they find challenging. The goal is to see if using CR resources provided to healthcare staff can improve the ability of participants to reach their personal goals and boost their confidence in handling their condition. The study will involve people with dementia, their caregivers, and clinical staff, who will work together to set goals related to daily activities. Participants will be asked to share their experiences, and the researchers will analyze this feedback to understand how well the program works.

To be eligible for the study, individuals must have a diagnosis of mild-to-moderate dementia and currently be receiving care from specific community mental health services. They should also have a caregiver who is willing to participate and can give consent. Caregivers must live with the person with dementia and be able to communicate in English. Staff participants must be part of the clinical team and have the necessary qualifications. Throughout the trial, participants can expect to set personal goals, receive support from staff, and share their thoughts on the program’s impact on their lives. If successful, the findings from this study could help improve services for people with dementia and their caregivers in Scotland.

Gender

ALL

Eligibility criteria

• • The study will include three participant groups: People with Dementia (PwD), their nominated people and staff participants.
• PwD:
• • Inclusion criteria
• • Diagnosis of mild/moderate dementia.
• • Currently on the caseload of OPCMHTs or the YOD service in NHSGGC.
• • Undergone assessment by OPCMHTs or YOD service and deemed as eligible for CR
• • Must have a carer that can act as their nominated person and is able to engage in the intervention and who will also need to provide informed consent.
• • If the PwD are taking dementia-specific medication, they need to have been receiving a stable dose for at least one month, with no expectation of change during the trial.
• • This study may include those who have a comorbid mental health disorder, brain injury, or other significant neurological disorder, where dementia is still considered by the patient's community mental health team to be the primary presenting difficulty. This is because we often see people who have dementia with comorbid health difficulties.
• • They must be proficient in the English language, in order to complete outcome measures.
• • Exclusion criteria
• • A diagnosis of severe/advanced dementia.
• • Those who do not have a carer than can act as their nominated person.
• • Those who lack the capacity to consent.
• Nominated people:
• • Inclusion criteria
• • They must live with the PwD.
• • They must be willing to take part in the intervention.
• • They must be able to provide informed consent.
• • They must be proficient in the English language.
• • Exclusion criteria • They lack the capacity to consent
• Staff participants:
• • Inclusion criteria
• • They must be part of the clinical team.
• • They must have health care degree which qualifies them for their post within the clinical team.
• • They must be proficient in the English language.
• • They must have access to clinical supervision (via a trainee or qualified clinical psychologist) to support their implementation of the NES resources.
• • Exclusion criteria
• • • They are not part of the clinical team.